THE MELANOMA DIFFERENTIATION-ASSOCIATED GENE MDA-6, WHICH ENCODES THE CYCLIN-DEPENDENT KINASE INHIBITOR P21, IS DIFFERENTIALLY EXPRESSED DURING GROWTH, DIFFERENTIATION AND PROGRESSION IN HUMAN-MELANOMA CELLS

被引:0
作者
JIANG, HP
LIN, J
SU, ZZ
HERLYN, M
KERBEL, RS
WEISSMAN, BE
WELCH, DR
FISHER, PB
机构
[1] COLUMBIA UNIV, COLL PHYS & SURG,INST CANC RES,DEPT PATHOL, CTR COMPREHENS CANC, NEW YORK, NY 10027 USA
[2] COLUMBIA UNIV, COLL PHYS & SURG,INST CANC RES,DEPT UROL, CTR COMPREHENS CANC, NEW YORK, NY 10027 USA
[3] WISTAR INST ANAT & BIOL, PHILADELPHIA, PA 19104 USA
[4] SUNNYBROOK HLTH SCI CTR, DIV CANC RES, TORONTO, ON M4N 3M5, CANADA
[5] UNIV N CAROLINA, LINEBERGER COMPREHENS CANC CTR, DEPT PATHOL, CHAPEL HILL, NC 27599 USA
[6] PENN STATE UNIV, COLL MED,MILTON S HERSHEY MED CTR,DEPT PATHOL, DIV EXPTL PATHOL, HERSHEY, PA 17033 USA
关键词
TERMINAL CELL DIFFERENTIATION; GROWTH CONTROL; MATRIGEL-ASSISTED PROGRESSION; METASTASIS SUPPRESSION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The combination of recombinant human fibroblast interferon (IFN-beta) and the antileukemic compound mezerein (MEZ) induces terminal differentiation with an irreversible loss of proliferative capacity in human melanoma cells, Using subtraction hybridization, cDNAs were identified that display enhanced expression in terminally differentiated and growth arrested human melanoma cells (Jiang and Fisher, 1993; Jiang et al., 1994a), A specific melanoma differentiation-associated (mda) cDNA, mda-6, is described whose expression inversely correlates with melanoma progression and growth, mda-6 is identical to WAF1/CIP1/SDI1 that encodes the M-r 21 000 protein (p21) that is an inhibitor of cyclin-dependent kinases, Actively growing normal melanocyte, SV40-immortalized human melanocyte and dysplastic nevus cell. lines synthesize elevated levels of mda-6 mRNA; whereas, actively proliferating radial and early vertical growth phase primary melanomas as well as metastatic human melanoma cells produce reduced levels of mda-6 mRNA, Treatment of primary and metastatic human melanoma cells with IFN-beta+MEZ results in growth inhibition and an increase in mda-6 expression, mda-6 expression also increases when human melanoma cells are grown to high saturation densities or when grown in serum-free medium, Using anti-p53 and anti-p21 antibodies, an inverse correlation is found between p53 and p21 protein levels during growth arrest and differentiation, Induction of growth arrest and terminal differentiation in H0-1 human melanoma cells by IFN-beta+MEZ results in a temporal decrease in wildtype p53 protein levels with a corresponding increase in p21 levels, In the Matrigel-assisted melanoma progression model, mda-6 expression decreases in early vertical growth phase primary human melanoma cells selected for autonomous or enhanced tumor formation in nude mice, In metastatic human melanoma cells displaying a loss of metastatic potential resulting from introduction of a normal human chromosome 6, mda-6 mRNA levels increase, Taken together, these studies indicate that mda-6 (p21) may function as a negative regulator of melanoma growth, progression and metastasis.
引用
收藏
页码:1855 / 1864
页数:10
相关论文
共 73 条
[1]  
ABDOLLAHI A, 1991, CELL GROWTH DIFFER, V2, P401
[2]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[3]   LACK OF ALLELIC DELETION AND POINT MUTATION AS MECHANISMS OF P53 ACTIVATION IN HUMAN-MALIGNANT MELANOMA [J].
CASTRESANA, JS ;
RUBIO, MP ;
VAZQUEZ, JJ ;
IDOATE, M ;
SOBER, AJ ;
SEIZINGER, BR ;
BARNHILL, RL .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (04) :562-565
[4]   TUMOR PROGRESSION AND THE NATURE OF CANCER [J].
CLARK, WH .
BRITISH JOURNAL OF CANCER, 1991, 64 (04) :631-644
[5]   POST-TRANSCRIPTIONAL CONTROL OF MYC AND P53 EXPRESSION DURING DIFFERENTIATION OF THE EMBRYONAL CARCINOMA CELL LINE-F9 [J].
DONY, C ;
KESSEL, M ;
GRUSS, P .
NATURE, 1985, 317 (6038) :636-639
[6]  
DUIGOU GJ, 1991, ONCOGENE, V6, P1813
[7]  
ELDEIRY WS, 1994, CANCER RES, V54, P1169
[8]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[9]   EFFECTS OF COMBINED TREATMENT WITH INTERFERON AND MEZEREIN ON MELANOGENESIS AND GROWTH IN HUMAN-MELANOMA CELLS [J].
FISHER, PB ;
PRIGNOLI, DR ;
HERMO, H ;
WEINSTEIN, IB ;
PESTKA, S .
JOURNAL OF INTERFERON RESEARCH, 1985, 5 (01) :11-22
[10]  
FISHER PB, 1986, ANTICANCER RES, V6, P765